Peptides & Peptide Synthesis Products

Fmoc-Lys(Mtt)-OH

Fmoc-Lys(Mtt)-OH
$25.00
$25.00
Fmoc-Lys(Mtt)-OH, Catalog No: 41088
N-α-Fmoc-N-ε-4-methyltrityl-L-lysine, CAS: 167393-62-6, MW: 624.77, Formula: C41H40N2O4
Catalog No: 41088
N-α-Fmoc-N-ε-4-methyltrityl-L-lysine, CAS: 167393-62-6, MW: 624.77, Formula: C41H40N2O4

* Required Fields

Description

Details

N-α-Fmoc-N-ε-4-methyltrityl-L-lysine
Additional Information

Additional Information

Catalog Number 41088
CAS 167393-62-6
M.W. 624.77
Formula C41H40N2O4
IUPAC Name (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methylphenyl)-diphenylmethyl]amino]hexanoic acid
Synonym N-α-Fmoc-N-ε-4-methyltrityl-L-lysine
Also Known As
  • (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4-methylphenyl)-di(phenyl)methyl]amino]hexanoic acid
  • (2S)-2-[(9H-fluoren-9-ylmethoxy-oxomethyl)amino]-6-[[(4-methylphenyl)-di(phenyl)methyl]amino]hexanoic acid
InChIKey YPTNAIDIXCOZAJ-LHEWISCISA-N
InChI InChI=1S/C41H40N2O4/c1-29-23-25-32(26-24-29)41(30-14-4-2-5-15-30,31-16-6-3-7-17-31)42-27-13-12-22-38(39(44)45)43-40(46)47-28-37-35-20-10-8-18-33(35)34-19-9-11-21-36(34)37/h2-11,14-21,23-26,37-38,42H,12-13,22,27-28H2,1H3,(H,43,46)(H,44,45)/t38-/m0/s1
SMILES CC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NCCCC[C@@H](C(=O)O)NC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46
Cited Uses

Details

1. Kijewska M et al, "Selective Detection of Carbohydrates and Their Peptide Conjugates by ESI-MS Using Synthetic Quaternary Ammonium Salt Derivatives of Phenylboronic Acids", Journal of the American Society for Mass Spectrometry, 25() pp.966-976 (2014).
2. Witte MD et al, "Production of unnaturally linked chimeric proteins using a combination of sortase-catalyzed transpeptidation and click chemistry", Nature protocols, 8(9) pp.1808-1819 (2013 Sep).
3. Guimaraes CP et al, "Site-specific C-terminal internal loop labeling of proteins using sortase-mediated reactions", Nature protocols, 8(9) pp.1787-1799 (2013 Sep).
4. Bąchor R et al, "New method of peptide cleavage based on Edman degradation", Molecular Diversity, 17(3) pp.605-611 (2013 Aug).
5. Sur S et al, "Tuning supramolecular mechanics to guide neuron development", Biomaterials, 34(20) pp.4749-4757 (2013 Jul).
6. Grünberg J et al, "DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl", PLoS ONE, 8(4) pp.e60350 ().
7. Wang Z et al, "Imaging mRNA expression levels in living cells with PNA?DNA binary FRET probes delivered by cationic shell-crosslinked nanoparticles", Organic & biomolecular chemistry, 11(19) pp.3159-3167 (2013 May 21).
8. Mossalam M et al, "Solid Phase Synthesis of Mitochondrial Triphenylphosphonium-Vitamin E Metabolite Using a Lysine Linker for Reversal of Oxidative Stress", PLoS ONE, 8(1) pp.e53272 ().
9. Webber MJ et al, "Controlled Release of Dexamethasone from Peptide Nanofiber Gels to Modulate Inflammatory Response", Biomaterials, 33(28) pp.6823-6832 (2012 Oct).
10. Matson JB et al, "Nanostructure-templated control of drug release from peptide amphiphile nanofiber gels", Soft matter, 8(13) pp.3586-3595 (2012 Apr 7).
11. Cheng C et al, "Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line", EJNMMI Research, 1() pp.34 ().
12. Gerona-Navarro G et al, "Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade", ACS Combinatorial Science, 13(5) pp.458-465 (2011 Sep 12).
13. EL Andaloussi S et al, "Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo", Nucleic Acids Research, 39(9) pp.3972-3987 (2011 May).
14. Josan JS et al, "Fluorescent and Lanthanide Labeling for Ligand Screens, Assays, and Imaging", Methods in Molecular Biology (Clifton, N.j.), 716() pp.89-126 (2011).
15. Huang Z et al, "Biological synthesis of tooth enamel instructed by an artificial matrix", Biomaterials, 31(35) pp.9202-9211 (2010 Dec).
16. Wang Q et al, "MULTICOLOR MONITORING OF DYSREGULATED PROTEIN KINASES IN CHRONIC MYELOGENOUS LEUKEMIA", ACS chemical biology, 5(9) pp.887-895 (2010 Sep 17).
17. Fantini D et al, "Critical lysine residues within the overlooked N-terminal domain of human APE1 regulate its biological functions", Nucleic Acids Research, 38(22) pp.8239-8256 (2010 Dec).
18. Lee JS et al, "Lipo-oligoarginines as effective delivery vectors to promote cellular uptake", Molecular bioSystems, 6(10) pp.2049-2055 (2010 Oct).
19. Erdem SS et al, "Mono-Amine Functionalized Phthalocyanines: Mwave-Assisted Solid-Phase Synthesis and Bioconjugation Strategies", The Journal of organic chemistry, 74(24) pp.9280-9286 (2009 Dec 18).
20. Patkar KA et al, "The Effects of C-terminal Modifications on the Opioid Activity of [N-BenzylTyr1]Dynorphin A-(1-11) Analogs", Journal of medicinal chemistry, 52(21) pp.6814-6821 (2009 Nov 12).
21. Josan JS et al, "Solid-Phase Synthetic Strategy & Bioevaluation of a Labeled ?-Opioid Receptor Ligand Dmt-Tic-Lys for In Vivo Imaging", Organic letters, 11(12) pp.2479-2482 (2009 Jun 18).
22. Li S et al, "Synthesis and characterization of a high-affinity ?v?6-specific ligand for in vitro and in vivo applications", Molecular cancer therapeutics, 8(5) pp.1239-1249 (2009 May).
23. Aimetti AA et al, "Human Neutrophil Elastase Responsive Delivery from Poly(ethylene glycol) Hydrogels", Biomacromolecules, 10(6) pp.1484-1489 (2009 Jun 8).
24. Mata A et al, "Micropatterning of bioactive self-assembling gels", Soft matter, 5(6) pp.1228-1236 (2009).
25. Huang Z et al, "Bioactive Nanofibers Instruct Cells to Proliferate and Differentiate During Enamel Regeneration", Journal of Bone and Mineral Research, 23(12) pp.1995-2006 (2008 Dec).
Reviews
cr